Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

B Y Ryoo; Y K Kang; Y H Im; Y J Kim; B S Kim; T Y Kim; S H Jung; J H Park; H J Baek; Y C Kim

doi:10.1097/00000421-199906000-00008

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Identifier:nobleid.org/w1/20260515/FD5B558C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FD5B558C.svg?ark=w1%2F20260515%2FFD5B558C)](https://nobleid.org/work/w1/20260515/FD5B558C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Identifier:nobleid.org/w1/20260515/FD5B558C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FD5B558C.svg?ark=w1%2F20260515%2FFD5B558C)](https://nobleid.org/work/w1/20260515/FD5B558C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work